The Proposed Pan-Canadian Guidance for Newborn Screening: What We Heard
Date: Tuesday, March 4, 1:00 p.m. to 2:00 p.m. ETLocation: Free online event In support of the Government of Canada’s National Strategy for Drugs for Rare Diseases, Canada’s Drug Agency established a Newborn Screening Advisory Panel to develop pan-Canadian guidance for decision-makers about newborn…
What We Heard: Improvements to Drug Reimbursement Reviews
Date: Thursday, March 6, 2025 Time: 2:00 p.m. to 3:30 p.m. ET Location: Free online event The Drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In January 2025, we published a consultation document…
10th Annual Forum: Pathways to Access and Reimbursement
Date: March 26 – 27, 2025Location: One King West Hotel, Toronto, ON Sudha Kutty, Executive Vice-President, Evidence, Products, and Services, will participate at the 10th Annual Forum: Pathways to Access and Reimbursement hosted by the Canadian Institute. She will be speaking during 2 sessions: “…